The World Health Organisation (WHO) confirmed on Wednesday that three new drugs are undergoing clinical trials in a bid to find effective treatments for COVID-19.
The WHO Director-General, Dr. Tedros Ghebreyesus, who disclosed this at a press conference in Geneva, Switzerland, listed the drugs as Artesunate, Imatinib and Infliximab.
The drugs, according to him, will be tested on COVID-19 patients in 52 countries across the world under the Solidarity PLUS programme.
The WHO chief revealed that there are 203 million confirmed COVID-19 cases across the world.
Solidarity PLUS is the largest global collaboration among the WHO’s 194 Member States with thousands of researchers in over 600 hospitals across the world participating.
READ ALSO: WHO donates 26 ventilators to Nigeria
Artesunate is a drug for the treatment of severe malaria, Imatinib is used for certain cancers, including leukemia while Infliximab is a remedy for Crohn’s Disease, rheumatoid arthritis, and other diseases of the immune system.
Ghebreyesus said: “We already have many tools to prevent, test, and treat COVID-19, including oxygen, dexamethasone, and IL-6 blockers.
“But we need more for patients at all ends of the clinical spectrum from mild to severe disease. And we need health workers that are trained to use them in a safe environment.
“The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalised for COVID-19. They are already being used to treat other conditions.”
Join the conversation
Support Ripples Nigeria, hold up solutions journalism
Balanced, fearless journalism driven by data comes at huge financial costs.
If you are motivated and passionate about building a global society, founded on justice, equity, fairness, transparency, accountability and superior knowledge, kindly consider donating to Ripples Nigeria’s solutions journalism.
Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.
INVESTIGATION: Inside UNILAG’s multi-million naira budgetary abuse and academic discord
The University of Lagos located in Nigeria’s commercial capital, Lagos, has been embroiled in controversies with allegations bothering on misappropriation of...
SPECIAL REPORT: Displaced residents of Zamfara battle hunger, as underfunding derails Nigeria’s nutrition goals
On paper, Muhammad Zayyanu is seven years old. The quiet boy who looks shorter for his age could not recollect...
INVESTIGATION: N7.3bn paid for unnamed projects; how Nigerian govt spent N2.2trn in six months
Analysing nearly 3,000 payments made by various Federal Government Ministries, Departments and Agencies (MDAs) over the previous six months (January...
INVESTIGATION… Delay rocks Nigerian govt’s promise of N30,000 covid-19 relief for artisans, others
Before the outbreak of the COVID-19 pandemic in February, 2020, Chukwudi Okoroigwe’s daily earnings as a bus driver was hardly enough to cater to the...
INVESTIGATION… Ten years after, communities count losses as AfDB, Cross River govt abandon road project
Ten years after the Cross River State government and African Development Bank (AFDB) jointly awarded the Yahe-Wanokom-Wanikade-Benue border road for...